TriSalus Life Sciences (TLSI) Change in Accured Expenses (2021 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Change in Accured Expenses of $160000.0 for Q1 2026, down 90.15% year-over-year from $1.6 million in Q1 2025, and down 76.88% quarter-over-quarter from $692000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Change in Accured Expenses (2021 - 2026) Analysis & Trends
TriSalus Life Sciences' Change in Accured Expenses history runs 6 years deep, the most recent figure standing at $160000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 90.15% year-over-year to $160000.0; the TTM figure through Mar 2026 stood at $556000.0 (up 122.65% YoY), while the FY2025 annual figure was $2.0 million, up 146.08% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $160000.0, down from $692000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $5.4 million in Q4 2023, with the low at -$4.6 million in Q3 2023.
- The 5-year median for Change in Accured Expenses is $214728.0 (2022), against an average of $345882.4.
- The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses jumped 1046.1% in 2022, then slumped 1486.36% in 2024.
- TriSalus Life Sciences' Change in Accured Expenses stood at $4.1 million in 2022, then jumped by 30.69% to $5.4 million in 2023, then slumped by 94.43% to $301000.0 in 2024, then surged by 129.9% to $692000.0 in 2025, then slumped by 76.88% to $160000.0 in 2026.
- Business Quant data shows TLSI's Change in Accured Expenses at $160000.0 in Q1 2026, $692000.0 in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | TriSalus Life Sciences | 307.22 Mn | 260.94 Mn | 9.90 Mn | -586,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -586,000.00 |
| Jun 30, 2026 | -586,000.00 |
| Mar 31, 2026 | 160,000.00 |
| Mar 31, 2026 | 160,000.00 |
| Dec 31, 2025 | 692,000.00 |
| Dec 31, 2025 | 692,000.00 |
| Sep 30, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 301,000.00 |
| Dec 31, 2024 | 301,000.00 |
| Sep 30, 2024 | -2.03 Mn |
| Sep 30, 2024 | -2.03 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Mar 31, 2024 | -305,000.00 |
| Mar 31, 2024 | -305,000.00 |